1-5 of 5
Robert A. Hegele
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol

Changting Xiao, Satya Dash, Cecilia Morgantini, Robert A. Hegele, Gary F. Lewis
Journal: Diabetes
Diabetes 2016;65(7):1767–1778
https://doi.org/10.2337/db16-0046
Published: 13 June 2016
View article titled, Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol
Open the PDF for Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol in another window
Journal Articles

Loss-of-Function Mutations in ABCA1 and Enhanced β-Cell Secretory Capacity in Young Adults

Michael R. Rickels, Eugen S. Goeser, Carissa Fuller, Christine Lord, Anne M. Bowler, Nicolai M. Doliba, Robert A. Hegele, Marina Cuchel
Journal: Diabetes
Diabetes 2015;64(1):193–199
https://doi.org/10.2337/db14-0436
Published: 14 August 2014
View article titled, Loss-of-Function Mutations in <em>ABCA1</em> and Enhanced β-Cell Secretory Capacity in Young Adults
Open the PDF for Loss-of-Function Mutations in <em>ABCA1</em> and Enhanced β-Cell Secretory Capacity in Young Adults in another window
Includes: Supplementary data
Journal Articles

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Emma M. Allister, Brian G. Sutherland, Dawn E. Telford, Cynthia G. Sawyez, Jane Y. Edwards, Janet M. Markle, Robert A. Hegele, Murray W. Huff
Journal: Diabetes
Diabetes 2009;58(10):2198–2210
https://doi.org/10.2337/db09-0634
Published: 10 July 2009
View article titled, Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
Open the PDF for Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance in another window
Includes: Supplementary data
Journal Articles

Free Fatty Acid-Mediated Impairment of Glucose-Stimulated Insulin Secretion in Nondiabetic Oji-Cree Individuals From the Sandy Lake Community of Ontario, Canada: A Population at Very High Risk for Developing Type 2 Diabetes

André Carpentier, Bernard Zinman, Nathalie Leung, Adria Giacca, Anthony J.G. Hanley, Stewart B. Harris, Robert A. Hegele, Gary F. Lewis
Journal: Diabetes
Diabetes 2003;52(6):1485–1495
https://doi.org/10.2337/diabetes.52.6.1485
Published: 01 June 2003
View article titled, Free Fatty Acid-Mediated Impairment of Glucose-Stimulated Insulin Secretion in Nondiabetic Oji-Cree Individuals From the Sandy Lake Community of Ontario, Canada: <subtitle>A Population at Very High Risk for Developing Type 2 Diabetes </subtitle>
Open the PDF for Free Fatty Acid-Mediated Impairment of Glucose-Stimulated Insulin Secretion in Nondiabetic Oji-Cree Individuals From the Sandy Lake Community of Ontario, Canada: <subtitle>A Population at Very High Risk for Developing Type 2 Diabetes </subtitle> in another window
Journal Articles

PPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy

Robert A. Hegele, Henian Cao, Christy Frankowski, Suresh T. Mathews, Todd Leff
Journal: Diabetes
Diabetes 2002;51(12):3586–3590
https://doi.org/10.2337/diabetes.51.12.3586
Published: 01 December 2002
View article titled, <em>PPARG</em> F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Open the PDF for <em>PPARG</em> F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy in another window